Cargando…
Advances in Medical Imaging: Aptamer- and Peptide-Targeted MRI and CT Contrast Agents
[Image: see text] Computed tomography (CT) and magnetic resonance imaging (MRI) are among the most well-established modalities in the field of noninvasive medical imaging. Despite being powerful tools, both suffer from a number of limitations and often fall short when it comes to full delineation of...
Autores principales: | Koudrina, Anna, DeRosa, Maria C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495450/ https://www.ncbi.nlm.nih.gov/pubmed/32954116 http://dx.doi.org/10.1021/acsomega.0c02650 |
Ejemplares similares
-
Aptamer-Targeted Gold Nanoparticles As Molecular-Specific Contrast Agents for Reflectance Imaging
por: Javier, David J., et al.
Publicado: (2008) -
Aptamer-conjugated Magnetic Nanoparticles as Targeted Magnetic Resonance Imaging Contrast Agent for Breast Cancer
por: Keshtkar, Mohammad, et al.
Publicado: (2016) -
Advanced Fusion Imaging and Contrast-Enhanced Imaging (CT/MRI–CEUS) in Oncology
por: Schwarze, Vincent, et al.
Publicado: (2020) -
A Peptide Targeted Contrast Agent Specific to Fibrin-Fibronectin Complexes for Cancer Molecular Imaging with MRI
por: Ye, Furong, et al.
Publicado: (2008) -
A Peptide Targeted Contrast Agent Specific to Fibrin−Fibronectin
Complexes for Cancer Molecular Imaging with MRI
por: Ye, Furong, et al.
Publicado: (2009)